ORTHOWORLD found that half of the funding announcements made in 1H16 were by companies seeking to commercialize products for spinal indications. Additionally, three others were companies with product portfolios heavily focused in spine.
Phygen received U.S. Patent Number 9,387,016 for the La Costa SnaplokISP interspinous device/This is the first patent issued for the La Costa line, which includes a number of patent-pending designs. La Costa SnaplokISP features the "no screws" stackable design that was initially announced by Phygen in 2011, and displayed at AAOS in 2012.Source:...
ORTHOWORLD found that half of the funding announcements made in 1H16 were by companies seeking to commercialize products for spinal indications. Additionally, three others were companies with product portfolios heavily focused in spine.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.